This was consistent with our results, because the risk factors in the gene signature EGFR and ITGA3 were downregulated while the protective factor CDKN2A was upregulated in HPV-positive HNSCC patients. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.